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Improving child cognition in impoverished countries is a public health priority. Yet, biological pathways
and associated biomarkers of impaired cognition remain poorly understood and largely unknown, respec-
tively. This study aimed to explore and quantify associations between functional plasma protein
biomarkers and childhood intellectual test performance. We applied proteomics to quantify proteins in
plasma samples of 249 rural Nepalese children, 6–8 years of age who, 1 year later at 7–9 years of age,
were administered the Universal Nonverbal Intelligence Test (UNIT). Among 751 plasma proteins quan-
tified, 22 were associated with UNIT scores, passing a false discovery rate threshold of 5.0% (q < 0.05).
UNIT scores were higher by 2.3–9.2 points for every 50% increase in relative abundance of two insulin-
like growth factor binding proteins (IGFBPs), six subclasses of apolipoprotein (Apo) and transthyretin,
and lower by 4.0–15.3 points for each 50% increase in relative abundance of 13 proteins predominantly
involved in inflammation. Among them, IGFBP-acid labile subunit, orosomucoid 1 (ORM1), Apo C-I, and
pyruvate kinase isoenzymes M1/M2 jointly explained 37% of the variance in UNIT scores. After additional
adjustment for height-for-age Z-score and household socio-economic status as indicators of long-term
nutritional and social stress, associations with 6 proteins involved in inflammation, including ORM1,
a-1-antichymotrypsin, reticulocalbin 1, and 3 components of the complement cascade, remained signif-
icant (q < 0.05). Using untargeted proteomics, stable, constitutive facets of subclinical inflammation were
associated with lower developmental test performance in this rural South Asian child population. Plasma
proteomics may offer opportunities to identify functional, antecedent biomarkers of child cognitive
development.
 2016 The Authors. Published by Elsevier Inc. This is an openaccess article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction
As child survival improves (The United Nations, 2015), attention
is turning to assessing and alleviating coexisting burdens of
stunted growth and suboptimal cognition among children in low
and middle income countries (Black et al., 2013; Grantham-
McGregor et al., 2007). Both conditions can be a consequence of
undernutrition (Black et al., 2013; Walker et al., 2011) and share
complexity and incomplete knowledge of their etiologies,
challenging effective prevention (Gale, 2005). Yet, while theSustainable Development Goals agenda for the year 2030 remains
focused on reducing childhood growth faltering (The United
Nations, 2014), similar multi-sectoral efforts to quantify the bur-
den and develop interventions to prevent impaired cognition are
lagging.
Difficulty and costs in deploying standardized tests across cul-
tures represent clear obstacles to advancing the child development
agenda (Prado et al., 2010). In addition, however, there remains
population data on the complex biosocial interactions and risk fac-
tors of impaired cognition that could assist in identifying groups at
risk (Turkheimer et al., 2003; Walker et al., 2007). Chronic expo-
sure to protein-energy and micronutrient deficiencies (i.e., iron
and iodine), infectious agents, environmental hazards, social stres-
ses, and lack of stimulation and learning opportunities, all deeply
rooted in poverty, have been identified as risk factors (Walker
et al., 2011), but leaving the question how these insults disturb
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unanswered.
During the past decade, emerging ‘‘-omics” studies have con-
tributed to exploring biological pathways and discovering molecu-
lar footprints associated with neurodevelopmental disorders
(Antonarakis et al., 2004; Bahado-Singh et al., 2013; Corbett
et al., 2007; Woods et al., 2015). The high-throughput technologies
are powerful in that they do not require prior knowledge, thereby
enabling unprecedented discovery and allow analysis of hundreds
of biological molecules with a single assay, providing comprehen-
sive insights into the multifactorial nature of cognitive deficits.
These advances, however, have yet to be applied to improve our
understanding of common biological pathways that underlie sub-
optimal development of cognitive function of children in the devel-
oping world, where the most serious loss of developmental
potential occurs (Grantham-McGregor et al., 2007).
The plasma proteome which is currently being explored for its
potential to advance assessment of nutritional and health status
of children (Cole et al., 2013; Lee et al., 2015; West et al., 2015)
may provide a novel opportunity to identify biomarkers of molec-
ular networks of homeostatic systems or other environmental
exposures that affect cognitive function of children. The plasma
protein milieu exhibits relative constancy within individuals over
time and reflects a systemic ‘‘sum” of tissue status in the body
(Anderson and Anderson, 2002). Neurotrophic and neuroendocrine
factors that play key roles in neuronal cell signaling, synaptic plas-
ticity and neurogenesis are present in plasma (Iughetti et al., 2011;
O’Dorisio et al., 2002). In addition, the plasma proteome contains
proteins whose expression are influenced by genetics, age, gender
and nutritional and health status that are known to be underlying
contributing factors of brain function (Dauncey, 2009). Plasma pro-
teins influenced by some of these risk factors may not directly
affect brain function, but can still indicate cognitive function as a
systemic response to conditions that affect both protein abundance
in plasma and developmental processes in the central nervous sys-
tem (CNS).
In this study, we hypothesized that proteins that directly medi-
ate or indirectly reflect cognitive function can be detected and
quantified in plasma, and thus provide a repertoire of biomarkers
that could provide insight into risk factors of poor cognition within
or between populations. In southern Nepal, as part of a follow-up
study in the offspring of women who participated in a prenatal
micronutrient supplementation trial, we collected plasma samples
at 6–8 years of age (Schulze et al., 2014; Stewart et al., 2009b). A
year later, intellectual and motor functioning were assessed by
standardized tests in a subgroup of the children at 7–9 years of
age (Christian et al., 2010) at the time when the brain for higher-
cognitive functions continues to mature (Grantham-McGregor
et al., 2007). Using existing plasma samples and applying quantita-
tive proteomics, we sought to identify plasma proteins that co-
varied with cognition a year later, reflected by child performance
on a standardized test of general intelligence.2. Methods
2.1. Study design, population, and subjects
Children assessed in this study were a subset of a cohort of 4130
children born to 4926 mothers in the southern plains district of
Sarlahi, Nepal who participated in a randomized controlled trial
of antenatal micronutrient supplementation from 1999 to 2001
(ClinicalTrials.gov:NCT0011527) (Christian et al., 2003a,b). Of
these, 3673 children subsequently (2001–2004) participated in a
second trial that evaluated growth effects of daily iron and/or zinc
supplementation from 6 to 36 months of age, (Tielsch et al., 2006)forming part of their history of nutritional exposure. In 2006–2008,
3524 children in this cohort were re-assessed at 6–8 years of age
for nutritional and health status, that included blood sample col-
lection (Stewart et al., 2009a,b). Children with available plasma
samples meeting inclusion criteria (n = 2130), were stratified by
the five antenatal supplementation groups, each from which 200
children randomly selected for in-depth biochemical biomarker
assessment (total n = 1000) (Schulze et al., 2014). From these,
plasma samples of 100 (50%) children from each of 5 maternal
micronutrient supplementation groups (total n = 500) were ran-
domly selected for mass spectrometric proteomics analysis (Cole
et al., 2013).
One year after the 2006-8 assessment, 1900 of the 3524 chil-
dren were followed for neurocognitive and motor function testing,
at 7–9 years of age (Christian et al., 2010). Thus, the present analysis
was carried out on a subset of 251 children from the original trial
whose records have both plasma proteomics data at 6–8 years of
age and intelligence test data at 7–9 years (Fig. 1). Two children
whose plasma samples appeared to be as a single sample within a
mass spectrometry experiment were further excluded, yielding
249 children for analysis. Children in the present study (n = 249)
were comparable based on numerous characteristics to other chil-
dren in the proteomics study who were not assessed for cognitive
function (also n = 249), except for a 0.6 kg heavier weight
(P = 0.022) (data not shown). Participation in all studies required
parental informed consent and all protocols were reviewed and
approved by institutional review boards in Kathmandu, Nepal and
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
2.2. Assessment of general intelligence
Children’s intellectual functioning was assessed using the
Universal Nonverbal Intelligence Test (UNIT). The UNIT was
designed to provide a measure of general intelligence in a com-
pletely nonverbal format for children who would be unfairly
assessed with a language-loaded ability test (Bracken et al.,
1998). It measures mainly memory and reasoning abilities consist-
ing of six subtests: symbolic, spatial, and object memory, analogic
reasoning, cube design, and mazes. Details about the administra-
tion of the UNIT and the standardization of raw scores have been
reported elsewhere (Christian et al., 2010). The analogic reasoning
subtest was removed because it was not culturally appropriate to
Nepalese children. Because this test has not been standardized in
Nepal, factor structure was assessed using exploratory and confir-
matory factor analyses. Total scores of the raw scores of five sub-
tests were generated and were converted to T-scores (mean 50
and standard deviation 10) based on child’s age.
2.3. Child nutritional and health assessments and household socio-
economic interview
Nutritional, health, demographic and socio-economic status
(SES) assessments during the follow-up surveys have been
described elsewhere (Stewart et al., 2009a,b). Briefly, during home
visits, trained staffs asked heads of household about children’s years
of schooling and household SES information (caste, religion, house-
hold asset ownership, parental education, and parental literacy).
Anthropometrists measured children’s height and weight by stan-
dard procedures and collected 7-day histories of morbidity symp-
toms and dietary intake (Stewart et al., 2009a). Plasma
concentrations of retinol, 25(OH)D, cobalamin, folic acid, transferrin
receptor, ferritin, and thyroglobulin were measured to assess child
vitamin A, D, and B12, folate, iron, and iodine status. For iron status,
transferrin receptor to ferritin ratio (TfR:ferr) was used (Malope
et al., 2001). High sensitive C-reactive protein (CRP) and alpha-1-
acid glycoprotein (AGP), two widely used inflammation makers for
Fig. 1. Consort diagram of study participants. Abbreviations: MN, micronutrient; UNIT, Universal Nonverbal Intelligence Test.
S.E. Lee et al. / Brain, Behavior, and Immunity 56 (2016) 253–263 255population studies in low resource settings (Raiten et al., 2015),
weremeasured by a benchtop clinical chemistry analyzer (Immulite
1000; Siemens Diagnostics) and a radial immunodiffusion assay
(Kent Laboratories), respectively, using the same plasma specimens
collected for proteomics analysis. Detailed information on biochem-
ical measurements was published elsewhere (Schulze et al., 2014).
Weight and height data were transformed to Z-scores based on the
WHO reference growth charts for children aged 5–19 years using
AnthroPlus software (de Onis et al., 2007).
2.4. Preparation of plasma samples and proteomics analysis
During the follow-up study in 2006-8, phlebotomists collected
early morning fasting samples of venous blood (10 ml in sodium
heparin-containing tubes without preservatives or antioxidants).
The biospecimens were centrifuged for plasma extraction. Plasma
was equally aliquoted into 4 tubes, frozen under liquid nitrogen,
shipped to the Johns Hopkins University in Baltimore, MD, USA
and stored at 80 C.
Proteomics analyses procedures have been previously described
(Cole et al., 2013). Briefly, plasma samples of the selected 500 chil-dren were immune-depleted to remove 6 highly abundant plasma
proteins (albumin, immunoglobulin A, immunoglobulin G, trans-
ferrin, haptoglobin, and anti-trypsin) to enhance the detection of
low abundant plasma proteins using a Human-6 Multiple Affinity
Removal 200 System (MARS) LC column (Agilent Technologies).
Immune-depleted samples were digested overnight by trypsin.
Seven randomly selected samples from 500 children and one refer-
ence sample were randomly labeled with 8 isobaric tags for rela-
tive and absolute quantitation (iTRAQ) reagent (AB Sciex). All
samples were mixed and fractionated into 24 fractions by strong
cation exchange (SCX) chromatography. iTRAQ-labeled peptides
were loaded to a reverse phase nanobore column and eluted pep-
tides were sprayed into an LTQ Orbitrap Velos mass spectrometer
(Thermo Scientific). MS/MS spectra were extracted using Thermo
Scientific Xtract software and searched against the RefSeq 40 pro-
tein database using Mascot (Matrix Science) through Proteome
Discoverer software (v1.3, Thermo Scientific). Peptides with high
confidence (>95%) were filtered with a false Discovery Rate < 5%.
Out of 72 iTRAQ experiments run for plasma samples of 500
children, 68 iTRAQ experiments for plasma samples of 249 children
with intelligence test outcome were used for analysis.
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Because child sex, age, and prenatal and childhood iron-folic
acid supplementation can be potentially associated with the out-
come based on previous studies (Christian et al., 2010; Murray-
Kolb et al., 2012), we considered the child characteristics as fixed
covariates and adjusted for them as initial child characteristics in
all models. In addition, we identified potential biological and psy-
chosocial risk factors based on the literature and data analysis
using uni- and multi-variate regression models (Supplementary
Table 1); viz., child iron and iodine status, long-term nutritional
status indexed by height-for-age Z-score (HAZ), body mass index
Z-score, school attendance, food intake in the previous week, mor-
bidity history in the past week, birth weight, ethnicity, caste,
HOME inventory score, wealth index, and maternal literacy and
education level (Christian et al., 2010, 2011, 2014; Patel et al.,
2013; Walker et al., 2011). A household wealth index was created
based on the first principal component of the polychoric correla-
tion of multiple indicators of household assets (materials of
ground, floor, and roof of house, bicycle, radio, television, electric-
ity, cattle, goat, and land). We selected covariates independently
associated with the outcome from the multivariate model. Among
the selected variables, ethnicity (Pahadi originating from the hills
and Madheshi originating from the plains), household wealth
index, maternal education, and child school attendance were
highly correlated with each other. We considered these as house-
hold socioeconomic and cultural risk factor variables and adjusted
for them in fully adjusted models.
2.6. Adjusting UNIT T-score for risk factors
The mean (standard deviation) score of UNIT was 50.4 (10.6),
ranging from 29.3 to 78.5. Because common underlying factors
(i.e., household SES) can confound associations between plasma
proteins and intellectual outcome or some plasma proteins may
mediate the effects of underlying factors (i.e., nutritional status)
on the outcome, we controlled for risk factor(s) to identify proteins
associated with the identified risk factors for generating future
hypotheses. We generated adjusted UNIT scores for different sets
of the risk factors by taking residuals from regression models with
UNIT T-score as a dependent variable and each or all risk factors as
independent variables in addition to the fixed child characteristics.
2.7. Statistical analyses
The process of estimating relative abundance of proteins mea-
sured by multiple iTRAQ experiments has been described else-
where (Herbrich et al., 2013). We employed linear mixed effects
models (LME) to combine the proteomic data from different exper-
iments and to estimate the association of protein relative abun-
dances with the UNIT score outcome. We fit a univariate random
intercept model with intelligence score as a dependent variable,
each protein as a fixed effect, and an iTRAQ experiment as a ran-
dom effect. Parameters were estimated using restricted maximum
likelihood estimation (Harville, 1977). We transformed beta-
coefficients (i.e., the fixed effect slope) to be interpreted as the esti-
mated change in the adjusted UNIT score associated with a 50%
increase (1.5 fold-change) in relative abundance of a protein. A
p-value was calculated by testing the null hypothesis of no associ-
ation between a protein and the UNIT score outcome. Multiple
hypothesis testing was corrected by controlling the false discovery
rate (FDR) (Storey, 2002). Proteins passing a FDR threshold of 5%
(q < 0.05) were considered significantly associated with the
outcome. The coefficient of determination (R2) was estimated by
calculating the correlation between the intelligence test score
and each respective best linear unbiased prediction from LME anal-ysis (Robinson, 1991). As number of plasma samples loaded per
iTRAQ experiment varied (ranged from 2 to 6), sensitivity analyses
was performed by restricting iTRAQ experiments with >2 plasma
samples to examine whether sample size per experiment affects
association between protein and the outcome.
Because multiple proteins participating in the same biological
processes can be highly correlated, we built a multiple-protein
regression model to estimate the variability in the UNIT scores
explained by a small subset of plasma proteins. Candidate proteins
for the model were selected based on their marginal associations
with the outcome (q < 0.05). The model started with a protein,
which was most strongly associated with the outcome. Additional
proteins, the next strongly associated with the outcome, were
allowed to enter the model as covariates based on a forward step-
wise procedure with a criterion that all included proteins should be
significantly associated with the outcome (P < 0.05).
General information of proteins was derived from the National
Center for Biotechnology Information (NCBI) Protein Database, Uni-
Prot Knowledgebase (Geer et al., 2010; The UniProt Consortium,
2014), and in-depth literature review. The dataset of UNIT score,
covariates, and relative abundanceof a subset of proteins is available
in Supplementary Table 2. All analyses were carried out using open-
source software implemented in the statistical environment R
(R Development Core Team, 2004).3. Results
3.1. Characteristics of study population
Characteristics of 249 children at their ages of blood collection
(7.5±0.4 yr) and cognitive assessment a year later (8.4±0.7 yr) are
summarized in Table 1, bywhich timeabout 67%and80%of children
had been to school. Although children had gained some weight and
height, their nutritional status remained low and stable over the
year with 35% stunted, 43% underweight, and 16% with a low body
mass index (BMI) at both visits based on WHO criteria. Plasma
micronutrient concentrations at the time of 1st visit are summarized
in Table 1. Deficiencies in vitaminA (retinol < 0.7 lmol/L), vitaminD
(25(OH)D < 50 nmol/L), folate (folic acid < 13.6 nmol/L), vitamin
B12 (cobalamin < 150 pmol/L), and iron (transferrin receptor to fer-
ritin ratio > 500 lg/lg)were present in 8.4, 18.5, 6.4, 20.1, and11.6%
of children using conventional cut-offs (Schulze et al. 2014).Weekly
dietary intakeswere comparable at each visit, reflecting a rice-based
diet supplemented with milk or curd, some vegetables and less fre-
quentmeat and egg intakes. Twenty-nine percent of children had an
elevated plasma AGP, suggestive of prolonged inflammation, while
6% had a raised CRP, possibly reflecting more acute infection, and a
rate that was comparable in magnitude those of lower respiratory
infection (2%) and diarrhea (4%) in the past week.3.2. Plasma proteins associated with the UNIT score
We analyzed a total of 751 proteins identified and quantified in
more than any 50 plasma samples of children. Among them,
twenty-two proteins (about 3% of total number analyzed) were
associated with initial child characteristics (age, sex, and, prenatal
and childhood micronutrient supplementation)-adjusted UNIT
scores, passing a discovery threshold of 5% (q < 0.05) (Table 2). Nine
proteins were positively associated with the outcome: insulin-like
growth factor (IGF) binding protein acid labile subunit (IGFALS),
IGF-binding protein 3 (IGFBP3), transthyretin (TTR), and 6
sub-classes apolipoproteins (APOA1, A2, C3, C1, D, and M). These
proteins are known to transport or regulate insulin-like growth fac-
tors, thyroid hormone, and lipids/cholesterol in the circulatory sys-
tem.UNIT scores increasedby2.39.2with a50% increase in relative
Table 1
Demographic, nutritional, health, and dietary characteristics of Nepalese children included in analysis at the time of blood sampling and cognitive assessment (n = 249)
Characteristics Values at blood sampling (2006-8)a Values at cognitive assessment (2007-9)a
Age, years 7.5 (0.4) 8.4 (0.7)
Ever sent to school, n (%) 167 (67.1) 198 (79.5)
Male, n (%) 122 (49.0) 122 (49.0)
Anthropometric measurements
Weight, kg 18.6 (2.9) 20.6 (3.2)
Height, cm 114.5 (5.9) 119.4 (6.3)
BMI, kg/m2 14.1 (1.2) 14.4 (1.4)
Stunting (HAZb < 2), n (%) 88 (35.3) 91 (36.5)
Underweight (WAZb < 2), n (%) 108 (43.4) 107 (43.0)
Low BMI (BMIZb < 2), n (%) 41 (16.5) 40 (16.1)
Plasma micronutrient status indicatorsc
Retinol, lmol/L 1.05 (0.26) –
25(OH)D, nmol/L 66.2 (18.1) –
Folic acid, nmol/L 23.8 (19.2, 30.4)d –
Cobalamin, pmol/L 236.3 (112.1)d –
TfR:ferr, lg/lg 203 (134, 317)d –
Diet in the past 7 days (P3 times), n (%)
Rice, corn, and wheat 248 (99.6) 249 (100.0)
Milk and curd 119 (47.8) 111 (44.6)
Egg 6 (2.4) 5 (2.0)
Fish, chicken, and other meat 17 (6.8) 29 (11.6)
Yellow vegetables and fruite 39 (15.7) 42 (16.9)
Dark green leafy vegetables 75 (30.1) 93 (37.3)
Plasma inflammation markersc, n(%)
AGP > 1.0 g/L 71 (28.5) –
CRP > 5 mg/L 14 (5.6)d –
Morbidity in the past 7 day, n (%)
Lower respiratory infectionf 5 (2.0) 6 (2.4)d
Diarrheag 11 (4.4) 11 (4.4)
Abbreviations: BMI, body mass index; WAZ, weight-for-age Z-score; HAZ, height-for-age Z-score; BMIZ, body mass index Z-score; TfR:ferr, transferrin receptor to ferritin
ratio; AGP, a-1-acid glycoprotein; CRP, C-reactive protein.
a Data are given as mean (standard deviation) or median (interquartile ranges) if distributions were skewed unless otherwise indicated.
b Z-score was defined by the WHO Growth reference 5–19 years.
c Blood samples were not collected at the time of cognitive assessment.
d Data are missing for folic acid (n=1), cobalamin (n=1), ferritin (n=2), and lower respiratory infection (n=2), and one outlier value for CRP was excluded.
e Yellow vegetables and fruit group includes mango, papaya, jackfruit, and pumpkin.
f Lower respiratory infection was defined by a history of productive cough or rapid breathing and fever in the past week.
g Diarrhea was defined by watery stools or dysentery in the past week.
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tein accounted for 17.6–24.8% of the variance in the adjusted UNIT
scores. Thirteen proteins were negatively associated with UNIT
scores including orosomucoid 1 (ORM1 or AGP1), components of
complement system (C2, C5, C9, and complement factor I), a-1-
antichymotrypsin (SERPINA3 or ACT), leucine-rich a-2-glyc
oprotein 1 (LRG1), and lipopolysaccharide-binding protein (LBP).
Most of these are acute phase proteins and others are intracellular
proteins with various biological functions including glycolysis and
the regulation of circadian rhythm. UNIT scores decreased by
4.0–15.3 per a 50% increase in relative abundance of each protein,
explaining 18.545.0% of the variance in the adjusted UNIT scores.
3.3. Proteins explained the variability in the UNIT score
A multiple-protein regression model showed that four proteins,
including IGFALS, ORM1, APOC1, and pyruvate kinase isozymesM1/
M2 (PKM) jointly explained 37% of the variance in the initial child
characteristics-adjusted UNIT scores (R2) (basic model; Model A in
Table 3). Additional adjustment for child iron status reflected by
log transformed transferrin receptor to ferritin ratio did not materi-
ally change the associations with the 4 proteins and R2 (Model B in
Table 3). However, controlling for the initial child characteristics
and child HAZ attenuated about 50% of the observed association
with IGFALS and reduced R2 to 30% (Model C in Table 3); controlling
for the initial child characteristics plus household SES characteris-
tics considerably attenuated the observed positive associationswith IGFALS and APOC1, and reduced R2 to 13% (Model D in Table 3).
WhenUNIT scores were adjusted for the initial child characteristics,
HAZ, and household SES, negative associations with ORM1 and PKM
remained significant, accounting for 11% of variance in the adjusted
outcome (Model E in Table 3).
3.4. Plasma proteins associated with the UNIT score after adjusting for
risk factors
Because adjusting for iron status did not substantially change
R2, we fit a single-protein model again with UNIT scores adjusted
for the initial child characteristics, child HAZ, and household SES
characteristics. Out of 751 proteins tested, six proteins—ORM1,
C9, CFI, ACT, reticulocalbin 1 (RCN1), and complement factor H-
related 5 (CFHR5)—were negatively associated with the adjusted
UNIT scores which decreased by 3.7–7.4 per a 50% increase in rel-
ative abundance of each protein (q < 0.05) (Table 4). These proteins
are all known to be involved in inflammation. Other inflammatory
proteins that did not pass the false discovery rate threshold of 5%
included LRG1 (q = 0.0697), ORM2 or AGP2 (q = 0.0907), LBP
(q = 0.0907), and CRP (q = 0.2911).
3.5. Validation of the proteomics findings with targeted inflammation
markers
In order to validate the observation that lower UNIT scores were
associated with increased relative abundance of inflammatory pro-
Table 2
Plasma proteins positively and negatively associated with intelligence test score in school-aged children in rural Nepal (q < 0.05)
Molecular/biological function Protein name (gene symbol)a nb b (95% CI)c R2d Accessione
Positively associated proteins
Transport/regulate insulin-like growth factors (Baxter, 1990) IGF-binding protein acid labile subunit (IGFALS) 249 7.1 (4.3, 9.9) 24.8 4826772
IGF-binding protein 3 (IGFBP3) 249 4.4 (1.9, 6.9) 18.6 62243068
Transport thyroxine and retinol (Kanai et al., 1968; Woeber
and Ingbar, 1968)
Transthyretin (TTR) 249 9.2 (4.8, 13.7) 20.8 4507725
Transport lipids/cholesterol (Alaupovic, 1982) Apolipoprotein A-I (APOA1) 249 7.4 (3.7, 11.1) 20.3 4557321
Apolipoprotein A-II (APOA2) 249 6.6 (3.1, 10.0) 19.6 4502149
Apolipoprotein C-III (APOC3) 249 3.6 (1.5, 5.7) 18.3 4557323
Apolipoprotein C-I (APOC1) 249 2.3 (0.9, 3.7) 17.9 4502157
Apolipoprotein M (APOM) 249 5.8 (2.1, 9.5) 17.6 22091452
Apolipoprotein D (APOD) 249 5.2 (1.9, 8.6) 17.6 4502163
Negatively associated proteins
Acute phase response (Gabay and Kushner, 1999) Orosomucoid 1 (ORM1) or a-1-acid
glycoprotein 1 (AGP1)
249 5.3 (7.5, 3.1) 23.5 167857790
Complement cascade (Janeway et al., 2001) Complement component 9 (C9) 249 7.6 (11.0, 4.3) 22.4 4502511
Complement factor I (CFI) 249 9.9 (14.3, 5.4) 22.0 119392081
Complement component 2 (C2) 211 15.3 (22.7, 7.9) 23.0 14550407
Complement component 5 (C5) 249 8.4 (13.2, 3.7) 18.7 38016947
Acute phase response (protease) (Gabay and Kushner, 1999) a-1-antichymotrypsin (SERPINA3 or ACT) 249 9.8 (14.2, 5.4) 22.2 50659080
Angiogenesis (Wang et al., 2013) Leucine-rich a-2-glycoprotein 1 (LRG1) 249 5.0 (7.6, 2.5) 19.9 16418467
ER calcium-binding protein (Ozawa and Muramatsu, 1993) Reticulocalbin 1 (RCN1) 59 6.2 (9.6, 2.9) 43.2 4506455
Regulate genome stability, cell survival, the circardian clock
(Engelen et al., 2013; Sakai et al., 2004)
Protein timeless homolog (TIMELESS) 62 13.4 (21.1, 5.8) 31.6 222136585
Acute phase response (Gabay and Kushner, 1999) Lipopolysaccharide-binding protein (LBP) 249 4.0 (6.3, 1.7) 18.5 31652249
Glycolysis (Marjanovic et al., 1990) Pyruvate kinase isozymes M1/M2 (PKM) 239 6.1 (9.8, 2.3) 20.7 33286418
Regulate of microtubule-based cilia function (van Rooijen
et al., 2008)
Leucine-rich repeat-containing protein 50 (DNAAF1) 107 4.4 (7.2, 1.7) 45.0 157674358
Modulate cell cycle, cytokinesis, and cellular membrane
traffic (Lim and Tang, 2013)
Ecotropic viral integration site 5 protein (EVI5) 134 4.5 (7.2, 1.7) 27.8 68299759
Abbreviations: IGF, insulin-like growth factor; ER, endoplasmic reticulum.
a A list of proteins passing a false discovery rate threshold of 5% (q < 0.05) among a total of 751 plasma proteins (number of child plasma sample > 50) tested by linear
mixed effect models. Proteins are ordered by direction of association and clustered by similar molecular/biological function.
b Number of child plasma samples in which a protein was detected and quantified by iTRAQ tandem mass spectrometry
c Estimated change in child characteristic (age, sex, and, prenatal and child micronutrient supplementation)-adjusted UNIT score per a 50% increase in relative abundance
of each protein.
d Percentage of variance in child characteristics-adjusted UNIT scores explained by protein.
e GenInfo sequence number as assigned to all nucleotide and protein sequences by the National Center for Biotechnology Information at the National Library of Medicine.
Table 3
Association between selected plasma proteins and intelligence test score in multiple-protein regression model in school-aged children in rural Nepal (n = 237)a
Gene symbol Model Ab Model Bc Model Cd Model De Model Ef
b (95% CI)g Ph b (95% CI)g Ph b (95% CI)g Ph b (95% CI)g Ph b (95% CI)g Ph
IGFALS 4.9 (2.0, 7.8) 0.0008 4.8 (2.0, 7.6) 0.0008 2.4 (0.4, 5.2) 0.0965 1.5 (1.1, 4.1) 0.2638 0.0 (2.6, 2.5) 0.9786
ORM1 3.5 (5.8, 1.3) 0.0021 4.0 (6.2, 1.9) 0.0003 3.4 (5.6, 1.2) 0.0021 3.4 (5.4, 1.3) 0.0011 3.5 (5.4, 1.5) 0.0006
APOC1 1.4 (0.0, 2.8) 0.0478 1.2 (0.2, 2.5) 0.0867 1.2 (0.1, 2.6) 0.0725 0.6 (0.6, 1.9) 0.3203 0.6 (0.6, 1.8) 0.3360
PKM 4.6 (8.1, 1.1) 0.0094 4.8 (8.2, 1.4) 0.0057 5.0 (8.4, 1.6) 0.0042 3.9 (7.1, 0.7) 0.0168 4.2 (7.3, 1.1) 0.0072
R2i 0.37 0.38 0.30 0.13 0.11
Abbreviation: IGFALS, insulin-like growth factor binding protein acid labile subunit; ORM1, orosomucoid 1; APOC1, apolipoprotein C-I; PKM, pyruvate kinase isozymes M1/
M2.
a Analysis was restricted to children (n = 237) with completed data for UNIT scores, selected 4 proteins and all covariates included in Model A-E.
b Model A: UNIT scores were adjusted for initial child characteristics (child age, sex, and prenatal and child micronutrient supplementation) (basic model).
c Model B: UNIT scores were adjusted for initial child characteristics and iron status (log transformed transferrin receptor to ferritin ratio).
d Model C: UNIT scores were adjusted for initial child characteristics and child height-for-age Z-score (HAZ).
e Model D: UNIT scores were adjusted for initial child characteristics and household characteristics (wealth index, maternal education, ethnicity, and schooling).
f Model E: UNIT scores were adjusted for initial child characteristics, HAZ, and household characteristics (fully adjusted model)
g Estimated change in adjusted UNIT score per a 50% increase in relative abundance of single protein in a multiple-protein regression model
h P-value calculated by testing the null hypothesis of no association between single protein and adjusted UNIT score in the multiple-protein regression model
i Total variance in adjusted UNIT scores explained by proteins in each model.
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between UNIT scores and two conventional inflammation markers,
AGP and CRP, measured independently by conventional
immunoassays. Children’s UNIT scores decreased by a mean of
2.3 (95% CI = 0.9, 3.7; P = 0.0015) per a 50% increase in plasma
AGP concentration the year before adjusting for other risk factors
(Fig. 2). The UNIT score was also less significantly negatively asso-
ciated with CRP than AGP, evident by a 0.4 (95% CI = 0.1, 0.8;
P = 0.0125) decrease per a 50% increase in CRP concentration,
adjusting for the same covariates.4. Discussion
Child development involves complex biological processes that
may be compromised by chronic malnutrition and constant expo-
sure to environmental hazards. Biomarkers may exist that broadly
reflect such conditions that, if associated with developmental
metabolic pathways, could help reveal biosocial causes and more
informed ways to address poor cognition in impoverished settings.
Using untargeted quantitative proteomics, this study among young
school-aged children living in rural Nepal explored associations
Table 4
Plasma proteins associated with intelligence test score adjusted for initial child characteristics, height-for-age Z-score, and household characteristics in school-aged children in
rural Nepal (q < 0.05)a
Molecular/biological function Protein name (gene symbol) nb b (95% CI)c R2d Accessione
Acute phase response (Gabay and Kushner, 1999) Orosomucoid 1 (ORM1) or a-1-acid glycoprotein 1
(AGP1)
249 3.7 (5.6, 1.9) 6.0 167857790
Complement cascade (Janeway et al., 2001) Complement component 9 (C9) 249 6.1 (8.9, 3.3) 7.0 4502511
Complement factor I (CFI) 249 7.4 (11.1,
3.7)
5.8 119392081
Complement factor H-related 5 (CFHR5) 241 4.7 (7.0, 2.3) 6.7 13540563
Acute phase response (protease) (Gabay and Kushner,
1999)
a-1-antichymotrypsin (SERPINA3 or ACT) 249 6.9 (10.6,
3.2)
5.2 50659080
ER calcium-binding protein (Ozawa and Muramatsu, 1993) Reticulocalbin 1 (RCN1) 59 5.0 (7.7, 2.3) 38.6 4506455
Abbreviations: ER, endoplasmic reticulum.
a A list of proteins passing a false discovery rate threshold of 5% (q < 0.05) among a total of 751 plasma proteins (number of child plasma sample > 50) tested by linear
mixed effect models. Proteins are ordered by molecular/biological function.
b Number of child plasma samples in which a protein was detected and quantified by iTRAQ tandem mass spectrometry.
c Estimated change in initial child characteristic (age, sex, and previous micronutrient supplementation), child height-for-age Z-score (HAZ), and household characteristics
(wealth index, maternal education, ethnicity, and child school attendance)-adjusted UNIT scores per a 50% increase in relative abundance of each protein.
d Percentage of variance in initial child characteristics, HAZ, and household characteristics adjusted-UNIT scores explained by each protein.
e GenInfo sequence number as assigned to all nucleotide and protein sequences by the National Center for Biotechnology Information at the National Library of Medicine.
Fig. 2. Associations between intelligence test score and alpha-1-acid glycoprotein (AGP) and other risk factors in a multivariate model in school-aged children in rural Nepal
(n = 247). Abbreviation: Transferrin receptor to ferritin ratio, TfR:ferr. X-axis denotes expected difference (or change) in UNIT score adjusting for other covariates in the
multivariate model. For AGP and iron status, estimated change in UNIT score was associated with a 50% increase in plasma AGP (g/L) and TfR:ferr (lg/lg) concentration,
respectively. A high TfR:ferr value represents poor iron status. Supplementation represents children whose mothers received antenatal micronutrient supplements during
their pregnancy that included iron and folic acid (vs. supplements that did not) during the original randomized clinical trial (Christian et al., 2010). Pahadi and Madheshi
represent two major ethnic groups. Childhood iron-folic acid supplementation variable was included as a fixed covariate in the multivariate model [b (95% CI) = 1.4 (3.5,
0.7), P = 0.1872] (not illustrated). Maternal education and household wealth index variables were not significantly associated with the outcome (P > 0.05) and dropped from
the model.
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year later by the UNIT, a measure of nonverbal general intelligence.
Proteins that transport insulin-like growth factors, thyroid hor-
mone, and lipids/cholesterol in circulation were associated with
increased UNIT test scores, while proteins largely involved in
inflammation were associated with decreased test scores that
remained significant after adjusting for long-term nutritional and
household socioeconomic status. Four proteins, representing
potentially different biological pathways, jointly explained 37% of
the variance in adjusted test scores of intellectual function. Collec-
tively, these findings suggest that aspects of child cognitive devel-
opment may be, in part, related to distinct but potentially
interrelated biological pathways including nutritional and
immunologic regulation.
4.1. Associations between inflammatory proteins and UNIT score
Intellectual test performance was negatively associated with
several established proteins known to be involved in systemicinflammation, including ORM1, complement components, ACT,
and LBP, lending credibility to similarly negative associations
observed with less well known reactants. Although biological func-
tions of LRG1, RCN1, leucine-rich repeat-containing protein 50, and
ecotropic viral integration site 5 protein remain elusive, our previ-
ous study revealed that they are part of a systemic response to
inflammation (Lee et al., 2015). Negative associations of ORM1,
ACT, RCN1, and complement components with the UNIT score,
independent of chronic stressors known to be associated with poor
development in poor societies, reflected by a childhood height-for-
age and household socioeconomic status (Patel et al., 2013; Walker
et al., 2011), implicate subclinical inflammation in repressing cog-
nitive development.
There is convincing prospective epidemiological evidence that
peripheral inflammation adversely affects cognition. In Bangla-
desh, pro-inflammatory cytokines at 6 months of age were associ-
ated with decreased motor scores at 24 months of age,
independent of linear growth at 6 months, family income, and
maternal education (Jiang et al., 2014). Among adult cohorts in
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between elevated concentrations of inflammation markers and
cognitive ability, controlling for health and socio-economic status
(Gimeno et al., 2008; Karlsson et al., 2010). These findings support
a complex and sustained communication between the peripheral
immune system and the CNS function.
It is plausible that cytokines, acting as upstream effectors of
identified inflammatory proteins, may play key roles in mediating
the effects of peripheral inflammation on the CNS (Wilson et al.,
2002). Although not detected by mass spectrometry in this study
possibly due to their low abundances in the circulation
(Anderson and Anderson, 2002), pro-inflammatory cytokines such
as IL-6 and TNF-alpha are known to induce a systemic acute phase
response in the peripheral compartment (Gabay and Kushner,
1999). Circulating cytokines can also induce inflammation in the
CNS believed to be responsible for disturbances in memory consol-
idation and synaptic plasticity, and poor cognition (Chen et al.,
2008; Krabbe et al., 2005; Reichenberg et al., 2001) with or without
crossing the blood-brain barrier (Quan and Banks, 2007). Other
mechanisms may also exist that enable access of circulating acute
phase proteins (e.g. AGP and ACT) to the CNS (Adam et al., 2001;
Goodman and Vulpe, 1961), but an insufficient number of studies
currently exist to establish these mechanisms.
Our proteomics findings suggest that some inflammatory pro-
teins such as ORM1 (i.e., AGP1), ACT, and complement components
(all q < 0.05 in Table 4) are more strongly associated with intelli-
gence test performance than other well-known inflammatory pro-
teins. For example, CRP, one of the most widely used inflammation
biomarkers, was significantly associated with the outcome based
on a conventional level of significance (P = 0.0241), but did not
pass the false discovery rate threshold of 5% (q < 0.05) after multi-
ple comparison correction (q = 0.2911). These findings were con-
sistent with results of two targeted inflammation markers, CRP
and AGP, that were quantified independently by conventional
immunoassays (Results 3.5). Other studies have also reported vary-
ing degree of associations depending on inflammatory markers in
older persons (Dik et al., 2005; Engelhart et al., 2004; Singh-
Manoux et al., 2014). In this population characterized by chronic,
subclinical inflammation, stable undernourishment reflected by
anthropometric indicators, and a low prevalence of acute infec-
tions (Schulze et al., 2014), it is possible that mild but prolonged
inflammation reflected by AGP or complement components consti-
tutively present in circulation and moderately reactive during
inflammation (Mackiewicz et al., 1993; Thurnham and McCabe,
2012) may disturb developmental cognitive processes of children.
As these proteins have been rarely evaluated in relation to cogni-
tion, this study identifies additional inflammatory markers for
investigations of suboptimal intellectual function in populations
where chronic inflammation and undernutrition are common.
4.2. Associations between insulin-like growth factor binding proteins
and UNIT score
Two IGF-binding proteins were positively associated with intel-
lectual test performance a year later: IGFALS and IGFBP3, both
known to form ternary complexes with IGF1 in circulation and
modulate its bioavailability (Boisclair et al., 2001). IGF1 itself, how-
ever, was not associated with the outcome (q=0.236), disputing a
posited role for peripheral IGF1 in cognitive development at this
childhood age (Berger, 2001; Popken et al., 2005). In British
school-aged children, serum IGF1 concentration was associated
with a verbal component of intelligence quotient test scores
(Gunnell et al., 2005). Discrepant results between studies may
relate to differences in living standards, and nutritional and educa-
tion status of children, as well as different domains of intellectual
function being tested. As our work is also revealing IGFALS andIGFBP3 to be the most sensitive of identified plasma proteins asso-
ciated with height-for-age (Lee et al. unpublished results, 2016), it
is possible that the observed positive associations indirectly reflect
other biological pathways, such as those involving growth hor-
mone on cognitive development (Nyberg and Hallberg, 2013) or
other strong but non-causal relationships between height and
intelligence (Gale, 2005).
4.3. Associations between apolipoproteins and UNIT score
Plasma abundance of six apolipoproteins was positively associ-
ated with subsequent UNIT test scores, which in our larger sample
of children (n = 500) showed strong positive associations with HDL
(all P < 0.0001). Evidence is currently lacking in industrialized
countries that peripheral apolipoproteins or cholesterol are associ-
ated with childhood cognitive function (Perry et al., 2009; Rask-
Nissila et al., 2000). As cholesterol in the brain is virtually isolated
from cholesterol in peripheral circulation (Bjorkhem and Meaney,
2004), the observed positive associations may represent confound-
ing by household socioeconomic status that can be positively
related to lipid profiles and cognitive performance of children.
However, we cannot rule out roles for plasma cholesterol modulat-
ing the immune system without crossing the blood-brain barrier
(Sena et al., 2012). There is also evidence that APOA1, which exerts
anti-inflammatory functions in the CNS, is supplied from circulat-
ing APOA1 in the plasma (Vitali et al., 2014). Without studies in
low-income countries where dietary quality is often low, it may
be too early to rebut potential effects of peripheral apolipoprotein
profiles on cognitive function.
4.4. Association between pyruvate kinase isoenzymes M1/M2 and
UNIT score
PKM was selected as a negative covariate in the multiple pro-
tein regression model with IGFALS, ORM1, and APOC1 suggesting
possible antagonism on cognitive processes. It is a rate-limiting
enzyme in glycolysis mediating cellular energy production
(Muirhead, 1990). It is known to act as a metabolic (glucose) sensor
that regulates cell growth, size, and apoptosis (Spoden et al. 2009).
In addition, studies suggest that it plays a critical role in sustaining
immunologic response of peripheral lymphocytes and activating
the innate immunity against pathogenic infections (Burge et al.
1976; Marjanovic et al., 1991). Although studies have been lacking
associating PKM to cognition, we postulate that the negative asso-
ciation observed in this study indicates increased metabolic stress
or requirement for cellular growth and immunologic response
(Gupta and Bamezai, 2010) that can potentially compromise devel-
opmental processes in the CNS. Collectively, the results from the
multiple protein regression model have revealed diverse biological
pathways, including systemic inflammation, regulation of insulin-
like growth factors, lipid transport/metabolism, and cellular energy
metabolism that may contribute to a complex biology of childhood
cognitive development.
4.5. Strengths and limitations
To our knowledge, this is the first study that has attempted to
quantitatively and temporally associate plasma protein abundance
to general intelligence test score, providing a systems perspective
to assessing child cognitive function, in a typically undernourished
South Asian setting. The untargeted proteomics approach enabled
us to detect a novel suite of plasma protein biomarkers whose
shared biological pathways strengthen the plausibility of the find-
ings. The year lag between blood sampling and cognitive function
testing (i) enabled us to rule out associations due to co-existing,
episodic health conditions that could occur in cross-sectional
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suggests that measures of protein abundance provide a stable
and refined index of protein status over time, as was observed with
anthropometric status in this population. Although this study
included a small fraction of a population cohort (Christian et al.
2010; Stewart et al., 2009a), studied children were typical in their
nutrition and health profiles to other child populations in rural
Nepal, minimizing concern about bias. Further, rich demographic
and nutritional data extending from prenatal to postnatal life
allowed us to account in the analysis for multiple risk factors of
child development.
Among the study’s limitations, many identified proteins are
viewed as ‘classic’ plasma proteins that may not be directly medi-
ating cognitive function. Neuropeptides or neurotrophins, such as
brain-derived neurotrophic factor, that are known to modulate
neural and cognitive function (Cohen-Cory et al., 2010; Gomez-
Pinilla, 2008) were not detected by mass spectrometry. These pro-
teins/peptides are generally present at low plasma concentrations
(pg/ml) (Iughetti et al., 2011; O’Dorisio et al., 2002) and, thus, were
probably undetectable under present study conditions. Finally,
while the range of changes in UNIT scores per increase in protein
abundance cannot be directly compared to other studies because
proteins were not quantified in an absolute scale, relative abun-
dance estimation has been shown to be valid in revealing the direc-
tion and strength of protein associations with other outcomes,
such as aspects of nutritional status (Schulze et al., 2016; West
et al., 2015).
5. Conclusions
This exploratory study revealed that plasma proteomics can
identify candidate proteins associated with intellectual test perfor-
mance in a typical, rural child population in South Asia. As the
importance of assessing subclinical inflammation is under-
recognized in the integrative child development agenda, additional
studies are needed to confirm associations between prolonged sub-
clinical inflammation and childhood cognitive function which can
stimulate investigation into the causes and prevention of chronic
inflammation early in life. Plasma proteins such as those identified
in this study could serve dual roles as functional indicators at the
intersection of both environmental stress and child development.
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